The FY20 PCRP Idea Development Award is intended to support new ideas that represent innovative
approaches to prostate cancer research and have the potential to make an important contribution to
the PCRP mission. The key components of this award mechanism are:
• Innovation: Research deemed innovative may represent a new paradigm, challenge current paradigms,
look at existing problems from new perspectives, leverage unique study populations, or exhibit
other highly creative qualities. Research that is an incremental advance upon published data is not
considered innovative. Projects involving multidisciplinary and/or data science approaches are
especially encouraged.
• Impact: Applications are required to address and provide a solution to one or more of the FY20
PCRP Overarching Challenges. The potential impact of the research, both short-term and long-term,
in addressing the FY20 PCRP Overarching Challenge(s) should be clearly described. High-impact
research will, if successful, significantly advance prostate cancer research and/or patient care.
• Preliminary Data: Due to this award’s emphasis on innovation, the presentation of preliminary
data relevant to prostate cancer and the proposed project is encouraged, but not required. Any
unpublished, preliminary data provided should originate from the laboratory of the Principal
Investigator (PI) or a member(s) of the research team. Regardless of whether preliminary data are
included, applications should be based on a sound scientific rationale that is established through
logical reasoning and/or critical review and analysis of the literature.